Why the study?
Does systolic annular velocity (S') measured during exercise echocardiography predict mortality and cardiac hospitalization in patients with systolic heart failure?
Does systolic annular velocity (S') measured during exercise echocardiography predict mortality and cardiac hospitalization in patients with systolic heart failure?
Systolic annular velocity (S') at peak exertion during stress echocardiography is a powerful independent predictor of mortality and cardiac hospitalization in patients with systolic heart failure, outperforming LVEF and VO2 peak.
Answers are grounded in this paper and cite their sources.
May support exercise S' for prognostic stratification in systolic HF; leaves open its incremental value pending prospective validation.
Resting echocardiography measurements are poor predictors of exercise capacity and symptoms in patients with heart failure (HF). Stress echocardiography may provide additional information and can be expressed using left ventricular ejection fraction (LVEF), or diastolic parameters (E/E'), but LVEF has some major limitations. Systolic annular velocity (S') provides a measure of longitudinal systolic function, which is relatively easy to obtain and shows a good relationship with exercise capacity. The objective of this study was to investigate the relationship among S', E/E' and LVEF obtained during stress echocardiography and both mortality and hospitalisation. A secondary objective was to compare S' measured using a simplified two-wall model. A total of 80 patients with stable HF underwent exercise stress echocardiography and simultaneous cardiopulmonary exercise testing. Volumetric and tissue velocity imaging (TVI) measurements were obtained, as was peak oxygen uptake (VO2 peak). Of the total number of patients, 11 died and 22 required cardiac hospitalisation. S' at peak exertion was a powerful predictor for death and hospitalisation. Cut-off points of 5.3 cm/s for death and 5.7 cm/s for hospitalisation provided optimum sensitivity and specificity. This study suggests that, in patients with systolic HF, S' at peak exertion calculated from the averaged spectral TVI systolic velocity of six myocardial segments, or using a simplified measure of two myocardial segments, is a powerful predictor of future events and stronger than LVEF, diastolic velocities at rest or exercise and VO2 peak. Results indicate that measuring S' during exercise echocardiography might play an important role in understanding the likelihood of adverse clinical outcomes in patients with HF.
No takes yet. Share an insight, caveat, or question.
Zalen et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: